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ABCTRACT  
Xerosis cutis in Mellitus diabetes is a common complication that if not treated can cause 
fissures, infections, ulcer and its prevention is fundamental. Herbal medicine has been 
contributing for the improvement of the healing process. The objective of this study was to 
analyze the therapeutic efficacy of a bio compound of essential oils for the treatment of xerosis 
cutis and fissures in the feet of diabetic patients in order to prevent upcoming complications. 
The studies were developed in Nova Friburgo, Brazil, with 47 diabetic adult patients with 
xerosis cutis and fissures in their feet, they were divided into two groups: CG (control n=22) 
treated with urea cream 10% and SG (study n=25) treated with the bio compound. The fissures 
were measured (length X width) and photographed every week. Measurement of the glycated 
hemoglobin: in the beginning of the treatment and 60 days later. Therapeutic efficacy: 
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decreased measures of the fissures; lack of complications (pain, bleeding and increase of the 
fissure area); healing time. The average of the decrease of the fissure area was alike. The 
complete healing of the fissure occurred: 52.9% in SG and 47.1% in CG. There was no 
significant difference in the decrease of the fissure in the patients with total healing. Time for 
healing: SG took in average 11.6 weeks and CG 12 weeks (non-significant difference). Product 
efficacy: 60% in SG and 36.4% in CG reported some recovery right in the first seven days. All 
patients reported recovery in the healing of the fissures and xerosis cutis. In SG all reported no 
pain, itch, burn sensation or edema in their legs or feet after the treatment with the bio 
compound, and in CG only 33.3% of them reported some recovery in local pain and no one of 
them reported any recovery in the edema in their legs or feet. The bio compound was efficient 
for the treatment of fissures and xerosis cutis in the feet of diabetic patients, providing 
hydration, skin recovery, absence of pain, itch, and decrease of edema, being indicated as an 
advantage for the treatment of fissures and xerosis cutis, regardlessly the glycemic level. 
Keywords: treatment, diabetes, xerosis cutis, healing, fissures. 
 
RESUMO 
Xerose cutânea no diabetes de Mellitus é uma complicação comum que, se não for tratada, pode 
causar fissuras, infecções, úlcera e sua prevenção é fundamental. Os fitoterápicos têm 
contribuído para a melhoria do processo de cicatrização. O objetivo deste estudo foi analisar a 
eficácia terapêutica de um composto biológico de óleos essenciais para o tratamento de xerose 
cutânea e fissuras nos pés de pacientes diabéticos, a fim de evitar as futuras complicações. Os 
estudos foram desenvolvidos em Nova Friburgo, Brasil, com 47 pacientes diabéticos adultos 
com xerose cutânea e fissuras nos pés, divididos em dois grupos: GC (controle n = 22) tratado 
com creme de ureia 10% e GE (estudo n = 25) tratados com o biocomposto. As fissuras foram 
medidas (comprimento X largura) e fotografadas todas as semanas. Medição da hemoglobina 
glicada: no início do tratamento e 60 dias depois. Eficácia terapêutica: diminuição das medidas 
das fissuras; falta de complicações (dor, sangramento e aumento da área da fissura); tempo de 
cura. A média da diminuição da área de fissuras foi semelhante. A cicatrização completa da 
fissura ocorreu: 52,9% em GE e 47,1% em GC. Não houve diferença significativa na 
diminuição da fissura nos pacientes com cura total. Tempo para cura: GE levou em média 11,6 
semanas e GC 12 semanas (diferença não significante). Eficácia do produto: 60% em GE e 
36,4% em GC relataram alguma recuperação correta nos primeiros sete dias. Todos os pacientes 
relataram recuperação na cicatrização das fissuras e xerose cutânea. No GE, todos relataram 
não ter mais dor, coceira, sensação de queimação ou edema nas pernas ou nos pés após o 
tratamento com o biocomposto, e no GC, apenas 33,3% relataram alguma recuperação na dor 
local e nenhum deles relatou recuperação no edema nas pernas ou nos pés. O biocomposto foi 
eficiente para o tratamento de fissuras e xerose cutânea nos pés de pacientes diabéticos, 
proporcionando hidratação, recuperação da pele, ausência de dor, coceira e diminuição do 
edema, sendo indicado como uma vantagem para o tratamento de fissuras e xerose cutânea, 
independentemente do nível glicêmico. 
 
Palavras-chave: tratamento, diabetes, xerose cutânea, cicatrização, fissuras. 
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1 INTRODUCTION 
Diabetes mellitus (DM) is highly prevalent in the world and it is the cause of major 
amputations of lower-limbs, factor of disability, handicap, early retirement and death. It is one 
the main causes of hospitalization, which leads to high financial costs (Milman et al., 2001). 
The diabetic foot is one of its most frequent complications and it is responsible for 50% - 70% 
of the nontraumatic amputations in lower-limbs, around 15 times more frequent in diabetic 
patients and responsible for 50% of hospitalizations (Bortoletto et al., 2009; Pascale et al., 
2012). 
Xerosis cutis (abnormally dry skin) is commonly observed in diabetic patients. Around 
30% of them present this problem and that is a reason why it may be an indicator of undiagnosed 
diabetes. It leads to the development of fissures that may be infected by bacteria, which is a 
factor of risk for the development of ulcers in diabetic feet (Federici et al., 2012). 
Fissure is a small crack in the callused skin of hands or feet, caused by the linear loss of 
epidermis and dermis, in areas of crease in the skin. Its origin is the elimination or destruction 
of the skin tissues caused basically by the loss of skin elasticity. Determinant factors for its 
occurrence are: xerosis, age, eating habits, amount of drunk water, use of certain medicines, 
skin contact with chemical products and soil, wearing of unsuitable socks or shoes, and obesity 
(Viana, 2011). The treatment for xerosis is skin hydration avoiding its development into fissures 
(Federici et al., 2012) that cause major problems for diabetic patients, they are proven 
uncomfortable and harmful, causing pain, itch and irritation (Viana, 2011). 
The healing process is complex and precarious in diabetic patients because 
hyperglycemia damages blood vessels that irrigate tissues, those may be blocked or harmed by 
excessive glycoses, jeopardizing organs that they irrigate and impairing the healing process 
(Andrade et al., 2013). The chronic wounds do not heal despite suitable care, they are hard to 
be treated (Reddy et al., 2012) and the current methods include antibiotics, skin grafts and 
proteolytic enzymes that have major disadvantages and unwanted side effects (Kumar et al., 
2007).  
Due to these side effects people search for alternative therapies for the problem of 
healing of the wounds instead of the modern therapies with antibiotics and corticoids, which 
enhances the importance of researches looking for drugs that are able to interact with the 
damaged tissue accelerating the healing process (Kumar et al., 2007).  
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Phytotherapy has been an excellent option for the treatment of wounds in the skin, as a 
new proposal of treatment, highlighting the essential oils, powerful emollients, healings and 
cellular regenerators (Malufe and Ajauskas, 2007; Shimizu et al., 2009). Natural products have 
been proven efficient for the treatment of wounds in the skin, giving results in a short period of 
use without side effects (Viswanathan et al., 2011). Essential oils, as the lavender oil 
(Lavandula angustifolia), melaleuca oil (Melaleuca alternifolia) (Tea tree oil), calendula oil 
(Calendula officinalis) and andiroba oil (Carapa guianensis) are proven to be powerful healings 
and cellular regenerators (Zuzarte et al., 2012; Labib et al., 2019).  
Therefore, the presente work studied the efficacy of a bio compound made with essential 
oils of dianthus (Eugenia caryophyllata) and melaleuca (Melaleuca alternifolia) for the 
treatment of fissures in the feet of type 2 diabetic patients, as a new way of treatment, preventing 
complications in their feet. 
Description of the tested product (antiseptic bio compound) 
The tested bio compound is a product made with essential oils of dianthus (Eugenia 
caryophyllata) and melaleuca (Melaleuca alternifolia), registered at Health Surveillance 
Agency (ANVISA) as a degree II product, with antiseptic, healing, empowering and revitalizing 
properties, produced by Magia da Mata Cosméticos Ltda.  
The bio compound underwent a clinical study of topical skin compatibility (primary 
skin irritation, cumulative skin irritation, dermal sensitivity, dermal photosensitivity, and 
dermal phototoxicity). No volunteers (85) presented significant cutaneous reaction (erythema, 
edema, papule or vesicle), it is then considered secure for topical use, because it did not induce 
irritation phenomena or cutaneous sensitivity and neither any type of photoallergies nor 
photoxicities along the period of study. It was cleared for commercialization for not presenting 
any known side effects along the study phase. It is currently in process of patent registration.  
 
2 MATERIAL AND METHODS 
Volunteers 
The work was carried out at Diabetes Association of Nova Friburgo, RJ (ADINF). Unicentric, 
random, controlled and parallel clinical trial approved by Comitê de Ética em Pesquisa com 
Seres Humanos of the Fluminense Federal University (Nº 652.283/2014). Criteria of inclusion: 
type 2 diabetic patients, adults, both genders, registered at ADINF, with xerosis and fissures in 
their feet. Criteria of exclusion: type 1 diabetic patients and those with ulcers in their feet or 
taking medicine for the treatment of the fissures in the skin. 
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Selection and Study Protocol 
The patients’ feet were examined in order to discover if they had xerosis and fissures 
and to choose the foot in which the product would be used (fissure with the biggest area). Every 
patient was randomly instructed for the application of the bio compound or the urea cream 10% 
(control) by the work team including the podiatrist and the ADINF’s physician. 
They were divided in two groups: the study group (SG) received the bio compound, and 
the control group (CG) received the urea cream 10%. Both products were provided by the 
company Magia da Mata Cosméticos Ltda. 
All the patients were instructed to clean the wounded area previously and then apply the 
bio compound or the urea cream 10% over it, massaging the area, every 12 hours; exam their 
feet daily and inform the evaluation staff about any abnormality. The compliance with the 
treatment was periodically monitored (twice a week) through in-person or telephone interviews 
along the whole period of study.  
The measurement of glycated hemoglobin (GlycHb) was carried out in the beginning of 
the treatment (day zero) and after 60 days. The venous blood samples were collected by expert 
technician and sent to analysis at Laboratório de Patologia Clínica Dr. Rhony Barros (Nova 
Friburgo, RJ) by the boronate affinity chromatography technician. According to Brazilian 
Society of Diabetes (2014) it is the most used criterion for the control and diagnosis of diabetes.  
Criteria for the evaluation of the therapeutic efficacy of the product 
The patients of both groups were examined weekly by the same staff for up to 119 days. 
The chosen wound was measured (length x width) and photographed in every phase of the 
evaluation (Sony digital camera, Cyber-Shot, model: DSC-W510, 12.1 megapixels). The 
limitation of the wounded area was done with adhesive tape and, later, measured with a caliper 
rule (brand: Digimess Instrumentos de Precisão, model LR44).  
Evaluation of the therapeutic efficacy: questionnaire, administered by the researcher in 
every visit, in relation to the: decrease of the measures of the wound; absence of complications 
such as: pain, bleeding and increase of the wounded area; healing time. 
Statistics 
Analyses carried out by the statistic software SPSS version 10.0.  
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3 RESULTS 
Characterization of the studied population 
Six volunteers out of 53 were excluded. Forty-seven type 2 diabetic patients concluded 
the study: 14 male patients and 33 female patients; average age 63 ± 11 years old, average 
weight 71.98 ± 13.26 Kg; average height 1.60 ± 0.1 m; average BMI 28.57 ± 4.88 Kg/m2; 
average glycemia 164.2 ± 86.82 mg/dL; average glycated hemoglobin 8.2 ± 1.89%; average 
systolic blood pressure 135.9 ± 16.1 mmHg and average diastolic 80.4 ± 9.9 mmHg. 
The admeasurement of the initial measures of the fissures on the first day of study 
showed in SG an initial average length of 15.00 ± 5.22 mm with initial average width of 1.7 ± 
0.6 mm (area 13.73 ± 8.70 mm2). In CG the fissures showed initial average length of 14.5 ± 
5.59 mm and initial average width of 1.5 ± 0.73 mm (area 12.37 ± 12.54 mm2). When the 
average reduction (mm2/week) of the wound between the groups was analyzed it was observed 
a significant reduction of the wound in both groups (0.98 mm2/week and 0.99 mm2/week in SG 
and CG respectively) with no significant difference (p=0.348) between them (Figure 1).  
 
Figure 1 – Average reduction (mm2/week) of the fissure area along 119 
days of treatment in study and control groups. 
 
 
All patients had progressive weekly reduction of the treated wound with both treatments 
but not all of them had complete healing. At the end of the study 34 patients presented complete 
healing of the fissure, 18 in SG (72.0%) and 16 in CG (72.7%). Although the other patients of 
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both groups did not have complete healing of the fissure at the end of the treatment, there was, 
in both groups, significant reduction of the wound (recovery). The analysis in terms of complete 
healing (cure) or reduction of the fissure (recovery) in each one of the groups showed no 
significant difference in the reduction of the fissure in SG (p=0.125) and in CG (p=0.858) 
(Figure 2). 
 
Figure 2 – Average reduction (mm2/week) in study and control groups according to the post-treatment final state:  
cure or recovery 
. 
 
 
 
The comparative analysis between the patients with complete cure of the fissures in the 
groups presented average reduction of the fissure of 1.04 ± 0.42 mm2 and of 0.94 ± 0.62 mm2 
(SG and CG respectively) with no significant difference between them (p=0.251). The same 
analysis considering the recovery aspect of the fissures showed no significant difference in the 
comparison of these data between the groups (average reduction of the fissure 0.81 ± 0.51 mm2 
and 1.11 ± 1.24 mm2 in SG and CG respectively) (p=0.945). 
All patients of both groups recovered significantly after every week in the healing of the 
fissures and the elimination of the xerosis in the treated foot. Photograph 3 shows the 
appearance of the heel of two patients, one of the SG and another of CG on the first and last 
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weeks of evaluation, revealing the efficacy of the products in reducing xerosis and noticeable 
healing of the fissures. It is evident through this record that the patient that used the bio 
compound presented less dry flaking feet compared to the one that used urea cream 10%. 
 
Figure 3 – Two patients’ heel appearance on the first and last weeks of treatment with the bio compound (study group-
A,B,C) and with urea cream (control group-D,E,F). A and D) fissure length; B and E) fissure width; C and F) last 
week of evaluation. 
 
 
 
The percentage analysis of the reduction of the initial area in relation to the final area of 
the fissure (%/week) has shown the weekly healing rate along the treatments. The average of 
weekly reduction in both groups was alike (p=0.949), 9.6% in SG and 9.0% in CG (Figure 4). 
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Figure 4 – Average rate from initial area reduction to final area (%/week) in control and 
study groups.  
 
 
When the average percentage rate of reduction of the fissures in each week (weekly 
healing rate) was compared in each groups (cure x recovery) there was a statistically significant 
difference among the SG patients (p=0.001) and among the CG patients (p=0.002), which 
evidences a higher percentage of healing for the final state of cure (unshown data). Despite the 
average rate of weekly healing is higher for the patients that had the cure of the fissure in both 
groups there was no significant difference among the patients with cure of the fissure when CG 
and SG were compared (p=0.825). Neither was there any significant difference (p=0.731) when 
the average rate of weekly healing was compared between both groups with wound recovery. 
Analysis of the healing time for each group: patients that have completed the whole 
treatment with complete healing of the fissure in SG took on average 11.6 weeks and CG 12 
weeks, with no significant difference in the healing time between the groups (p=0.769) (Figure 
5). 
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Figure 5 – Complete healing time of the fissure (cure) in control and study groups.  
 
Note: ADINF = Associação de diabéticos de Nova Friburgo 
 
A significant difference was observed when the values of initial glycated hemoglobin 
(GlycHb-i) and final glycated hemoglobin (GlycHb-f) of both groups were compared. In SG 
the average GlycHb-i was 8.34 ± 1.79% and the average GlycHb-f was 7.37 ± 1.25% 
(p<0.0001). In CG the average values of average GlycHb-i was 8.13 ± 2.04% and average 
GlycHb-f was 7.95 ± 2.01% (p=0.012), which evidences a decrease in the average values of 
final glycated hemoglobin compared to the initial ones in both groups (Figure 6). 
 
Figure 6 – Comparison between GlycHb-i and GlycHb-f values in control and study groups.  
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Note: GlycHb-i: initial glycted hemoglobin; GlycHb-f: final glycated hemoglobin; ADINF = 
Associação de diabéticos de Nova Friburgo. 
 
When the values of GlycHb-i and GlycHb-f were compared between CG and SG no 
significant difference was observed (p=0.445 e p=0.107, respectively for initial and final 
values), which demonstrates that both presented the same behavior and were homogeneous. 
Analysis of the GlycHb variable in CG and SG groups in relation to the recovery and 
cure of the fissure: there was no significant difference intra or intergroups (p>0.5, unshown 
data). When the fissure-recovery aspect was considered in both groups in relation to the values 
of GlycHb-i and GlycHb-f, no significant difference was observed between the these values in 
CG (p=0.308) nor in SG (p=0.063) (unshown data). Regarding the fissure-cure aspect the values 
of GlycHb-i and GlycHb-f did not present significant difference in CG either (p=0.125). 
However, in SG a significant difference was observed in relation to the same parameters studied 
(p<0.0001). 
Table 2 shows the results of the analysis of the weekly questionnaire about the personal 
evaluation of the efficacy of the product: 60% of the patients in SG observed some recovery 
right after the first seven days of use of the bio compound versus 36.4% of the patients in CG. 
All of the patients of both groups reported 100% of improvement in the healing of the fissures, 
in the xerosis of the treated feet, feeling them smoother, less flaky and rough. All the patients 
who used the bio compound and felt some pain in the wound area reported that this sensation 
and discomfort disappeared. The patients that used urea cream 10% only 33.3% reported 
disappearance of the wound area pain. After seven days of treatment with the bio compound all 
of the patients reported that the itch was eliminated. Furthermore, other symptoms were edema 
and burn sensation in the feet and legs that, in some individuals, impaired their walking and 
wearing shoes. All the patients that used the bio compound reported the recovery of the edema 
and burn sensation, some of them reported improvement in the walking and regular wearing of 
shoes. No patients that used urea cream 10% reported any recovery of the itch or edema. 
        
   4 DISCUSSION 
Xerosis cutis and cutaneous fissures are common in type 2 diabetic patients, which 
bother and impair those patients’ social lives and personal relations. The dry and rough aspect 
of xerosis occurs mainly in the heel (Morgan, 2013). The fissures become severe most of the 
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times, which causes intense pain, burn sensation and discomfort, besides other complications 
such as ulcers (Onselen, 2011).  
DM causes extensive damages to the skin and most of the times the healing process is 
not completed, which provokes irreversible wounds (Andrade et al., 2013). The maintenance 
of the hyperglycemia leads to damages in several tissues of the body. The vessels may be 
blocked or harmed by the hyperglycemic condition, which causes damages to the organs that 
they irrigate and it may impair the process of repairing and healing, precarious slower process 
in those patients due to less collagen synthesis and connective tissue injury (Andrade et al., 
2013; Mendonça and Netto, 2009). Phytotherapy medicines have been efficient for the 
treatment of xerosis and fissures, as a new proposal of treatment, highlighting essential oils for 
being powerful emollients, healings and cellular regenerators (Malufe and Ajauskas, 2007; 
Shimizu et al., 2009).  
 The studied population presented high average weight and BMI for their age which leads 
to higher pressure in the lower-limbs increasing the risk of xerosis and fissures in their feet. 
These factors added to the high average glycemia (164.2 mg/dL) and uncontrolled diabetes on 
the average of the population (average GlycHb = 8.2%) show that this population must receive 
priority attention. According to SBD compensated diabetic patients are those who maintain 
GlycHb < 7% (Guidelines of the Brazilian Diabetes Society, 2014). 
Urea cream 10% was chosen as control because at ADINF it is the recommended 
treatment for xerosis and fissures producing good results in diabetic feet. The 10% 
concentration is most recommended but it may result in adverse symptoms such as burning and 
tingling (Addor et al., 2009). Due to prejudicial effects of chemical products many studies about 
herbal cosmetics have been carried out. Polyherbal cosmetic formulations have been 
recommended for long-term use and their effects are well-accepted and proven for the treatment 
of wounds in the skin. The search for alternative therapy for the problem of wound healing is 
common even in more economically developed countries despite the modern therapies with 
antibiotics and corticoids (Kumar et al., 2007).  
Both products tested were efficient in the treatment of xerosis and fissures in the 
patients’ feet, which promoted revitalization, hydration and healing of the wounds. The average 
of reduction of the fissure area was not significantly different when the groups were compared 
to each other, which demonstrates that the bio compound was as efficient as the urea cream for 
treating fissures and xerosis in diabetic patients’ feet. 
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The bio compound did not provoke side effects along the test for up to 119 days. Natural 
products are generally harmless or they have less side effects compared to synthetic drugs. 
These results are in agreement with the studies of Malufe and Ajauskas, 2007; these studies 
show the healing effects of different essential oils: calendula (Calendula officinalis) with anti-
inflammatory, emollient, antiseptic and healing properties; dianthus (Dianthus caryophyllus) 
with anti-infective and healing properties; lavender (Lavandula angustifolia) cellular 
regenerator effect and healing property; melaleuca (Melaleuca alternifólia) with proven 
healing, antiseptic, fungicide and bactericidal properties (Malufe and Ajauskas, 2007).  
There was progressive weekly reduction of the treated fissure area in every patient with 
both products and even those who completed the treatment without complete healing of the 
fissures had significant reduction of the initial area of the fissure.  
The analysis of the average reduction of the fissure in SG and CG presented no 
significant difference between the final states of cure and recovery. When cure and recovery 
were considered between the groups there was no significant difference either, which shows 
that the treatment with the bio compound and the one with urea cream were equally efficient.   
Herbal products are efficient healings in diabetic patients (Viswanathan et al., 2011). Such study 
confirms the results described showing that herbal products, such as essential oils, when 
compared to other synthetic products for the same purpose, are as efficent or even better for the 
healing of the skin, with the advantage of being safer because they have less side effects. 
The average rate of reduction from the initial area to the final area of the fissure 
(%/week) showed that although this reduction was alike in both groups, patients of them both 
who had the cure had a higher rate of healing (almost the double) than those patients that had 
the recovery, both in SG and in CG. The bio compound was efficient for the treatment of these 
wounds, again, in the same proportion as the synthetic product (urea cream 10%). It is possible 
to suggest that, by the results of the evolution in the healing of the fissure, with more time of 
treatment with the bio compound or urea, the patients that had some recovery would have the 
cure of the fissure.  
When the fissure cure aspect was evaluated in both groups the biocompound was also 
as efficent as the urea cream in the healing process, which suggests that the bio compound could 
be an alternative treatment for the healing of fissures in the diabetic feet. Plants and their 
derivatives have been a new attempt of medicine in aid healing in diabetic feet. Many herbal 
moisturizers have already been studied and their efficacy in aid skin, muscle and lymphatic 
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function regeneration was proven (Viswanathan et al., 2011). The bio compound by its 
composition is an excellent healing, regenerator and revitalizing of the skin. 
Both products also had very similar fissure healing time (11.6 e 12 weeks, respectively). 
These data confirm literature that shows that herbal products have results in short-tem use 
besides being efficient healings, despite the healing process to be precarious and long in diabetic 
patients and many times not completed successfully (Andrade et al., 2013). This work suggests 
that three months of treatment with two daily applications is time enough for the cure of fissures 
in around two thirds of the studied population. This shows the necessity of intensive daily care 
with the diabetic foot in order to prevent the formation of fissures and their development into 
ulcers.  
Through this study, it was not possible to explain why some patients in both groups had 
complete healing of the fissure and other did not, since both developed significantly into the 
reduction of the wound. Possibly, hyperglycemia, known as a factor that impairs the healing 
process, and insulin, that acts as growing factor for keratinocytes which influences their 
proliferation and differentiation, may have been the factors that interfered with the healing 
process. However, taking into consideration that the average glycemia of the population was 
high along the study, the possibility of this portion of the population that had just some recovery 
of the fissure have not followed the instructions about the application of the product properly 
is not excluded.  
The determination of the glycated hemoglobin is, according to Brazilian Diabetes 
Society (Guidelines of the Brazilian Diabetes Society, 2014), the most used criterion for both 
the control and the diagnosis of diabetes. Both dosages of glycated hemoglobin in all patients 
of both groups aimed the knowing of the disease situation in the beginning of the treatment of 
the fissure and the probable interference of the glycemic control in the healing process along 
the treatment (Andrade et al., 2013, Terranova, 1991).  
The comparison of GlycHb-i and GlycHb-f in both groups presented a reduction in the 
levels of GlycHb at the end of the study, which suggests that the intervention, somehow, caused 
a change in the eating habits or in the treatment (proper use of the medication) or even more 
attention to the problem because both groups had GlycHb-f decrease. These data show that the 
care with the diabetic patient and the proper attention to a problem that most of the times is not 
taken into account, as the presence of fissures, may lead the patients to a new behavior towards 
the disease treatment. Taking care of a diabetic patient is taking care of the whole. Fissures are 
proven uncomfortable and harmful, not only physically but psychologically (Viana, 2011). 
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Many patients reported not leaving their houses because of shame of their feet appearance or 
walking difficulties due to the pain caused by the fissures.  
The comparison of the GlycHb values in study and control groups related to recovery 
or cure of the fissure did not present significant difference. The same occurred when recovery 
and cure were analyzed in each group, which shows that the difference of the healing rate 
between the patients that had cure or recovery does not seem to be due to glycemic control. In 
literature several works about the glycemic interference in the healing process show that 
hyperglycemia in the diabetic patient provokes some difficulty in the healing process due to the 
impairment of the blood perfusion, which interferes with the proper oxygen, nutrients, and 
antibiotics supply, mainly in the lower-limbs. Hyperglycemia leads to the disruption of the early 
stages of repair, causing a delay in the tissue regeneration process (Andrade et al., 2013). The 
results of this study suggest that the level of GlycHb did not interfere directly with the healing 
process because the patients had average GlycHb above the maximum level (7%) recommended 
for the glycemic control in diabetic patients. The healing process of fissures in these patients 
was not influenced by the GlycHb rate found.  
There was no significant difference related to the cure and recovery taking into 
consideration the variation of GlycHb in the groups. The same was found when the values of 
GlycHb-i and GlycHb-f were considered in relation to the fissure recovery aspect, which shows 
that in the population with no complete healing the values of GlycHb did not have any 
influence. When the cure aspect was analyzed no significant difference was found either, 
however in the study group the difference between GlycHb-f and GlycHb-i in the patient with 
cure of the fissure was significant. This reveals that in the patients that completed the treatment 
with the bio compound and total healing of the fissure (cure) there was a significant decrease 
of the daily glycemic levels along the months of treatment. Since these glycemic levels did not 
differ in the recovery and cure aspects when compared in the same group, both had statistically 
similar decreases from GlycHb-i to GlycHb-f, it is not possible to affirm that the decrease in 
GlycHb is responsible for the complete healing in the patients that had the cure of the fissure, 
neither can it be assured that the bio compound was more efficient in its purpose of healing and 
revitalization of the wounded skin of the diabetic patient in comparison to the urea cream 10%. 
Further studies will be carried out for clarification. 
In the patients’ personal evaluations about the bio compound 60% of them reported 
some recovery right after the first seven days of use, with evident healing of the fissures, 
recovery in the xerosis of their feet, feeling them smoother, less flaky and rough. Literature 
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defines that good products for the treatment of xerosis of feet must show some recovery after 
at least seven days of treatment (Nayak, 2011; Terrie, 2013). The application of formulations 
containing oils and hygroscopic elements contribute for the reestablishment of the barrier of the 
skin, which permits the maintenance of the proper water levels and the effect is immediately 
felt after the application, with recovery of the xerosis, roughness and flakiness (Addor et al., 
2009). Not only did the bio compound eliminate the xerosis and the fissures but it also hydrated 
and revitalized the patients’ skin that had dry flaky aspect.  
The patients also reported relief of the pains and the discomfort of walking and wearing 
shoes, a very common pain in those who have fissures, according to Viana (Viana, 2011). The 
skin gets dry, rough with fissures that may crack, causing bleeding and pain that are the main 
symptoms of fissures. The bio compound was efficient in ending local pain in all patients with 
fissures while only 33.3% of those who used urea cream 10% reported a decrease in local pain. 
The bio compound has dianthus (Eugenia caryophyllata) essential oil as its component which 
is known as a powerful analgesic and anti-inflammatory, working also as an antiseptic against 
bacteria and fungi (Mehta et al., 2013). This oil has eugenol as its main component and it is 
responsible for its medical properties (Singh et al., 2012) and the melaleuca essential oil has 
antimicrobial and anti-inflammatory properties (Edmondson et al., 2011). 
Another aspect evaluated was the patients’ report about the itch between the toes and on 
the feet where there was xerosis and the treated fissure. Itch is very common in those who have 
rough skin, especially if the skin with xerosis is also observe in the forearm, hand and elbows 
(Terrie, 2013). All patients with itch reported its disappearance fter seven days of use of the bio 
compound but not with the use of the urea cream 10%. The essential oils are proven efficient 
antimicrobial against fungi and bacteria (Pazyar et al., 2013). A severe fungi infection may be 
treated with basil, melaleuca, sage and dianthus essential oils. These oils impair aerobic bacteria 
and fungi growth (Misner, 2007). It is possible that the fissures in the feet of the patients that 
reported pain and itch were infected by microorganisms that were eliminated after the use of 
the bio compound, since it is a product made with antiseptic property essential oils. In vitro and 
in vivo investigations in literature suggest that essential oils may be used as antifungal agents 
(Tabassum and Vidyasagar, 2013). Nevertheless, studies still need to be carried out to prove 
that the bio compound used in this work has antifungal activity. The bio compound was efficient 
in the healing and hydration of the skin and in the relief of the itch and pain.  
Patients reported, besides, that they had edema and felt a burn sensation in their legs and 
feet, and that it even impaired their walking. Diabetic patients may develop Charcot foot 
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(neuropathic osteoarthropathy), which is characterized in its acute phase by classic signs of 
inflammation (heat, redness, edema, with or without pain) and in its chronic phase by major 
deformities, leading to changes in the normal pattern of the foot (Lemos and Dullius, 2009). 
After the use of the bio compound the patients felt recovery of the edema and the burn sensation 
disappeared, which permitted them to walk normally, which did not occur with the use of the 
urea cream. Essential oils such as the dianthus one are excellent antimicrobial and anti-
inflammatory (Edmondson et al., 2011) and the use of the herbal product leads to good results 
in the healing of diabetic patients, in the collagen synthesis, in the blood circulation, besides 
the microbial and anti-inflammatory activities (Viswanathan et al., 2011).  
There are diverse evidences that natural products such as essential oils and plant extracts 
may have less harmful secondary effects to health than synthetic drugs. Essential oils and their 
components have multiple biological activities, such as antimicrobial and antioxidant properties 
(Wang et al., 2010; Silva et al., 2015; Monteiro et al., 2013). Because it is totally natural and 
made with essential oils, the bio compound may replace advantageously the use of synthetic 
medication that may turn microorganisms multiresistant, besides preventing many side effects. 
The dissemination of pathogens resistant to drugs is one the most serious threatens to the 
success of microbial diseases and, because they do not cause this dissemination, essential oils 
and plant extracts have been arousing interest as sources of natural treatment (Tabassum and 
Vidyasagar, 2013). 
The patients with xerosis and fissures must be instructed to avoid the use of creams and 
lotions that contain alcohol, perfume or coloring, since they can increase dryness and lead to a 
major skin irritation. Although the result in the healing of fissures has been similar to the result 
urea cream’s, the bio compound proved to be efficient not only in the healing of fissures but 
also in the elimination of xerosis and, besides, its antiseptic, revitalizing and analgesic 
properties were proven. Furthermore, because it is a compound produced with essential oils, it 
worked as a powerful moisturizer, easily absorbed by the skin, which showed good results after 
just seven days of use. As it is completely natural it does not irritate the skin and neither does 
it have adverse effects that may harm the wounds even more.  
 
5 CONCLUSION 
The bio compound has been as efficient as the urea cream for the treatment of fissures and 
xerosis in the feet of diabetic patients, being efficient for the hydration and revitalization of the 
treated patients’ skin. It was also effective for the elimination of itch and the reduction of the 
Brazilian Journal of health Review 
 
Braz. J. Hea. Rev., Curitiba, v. 2, n. 6, p. 5974-5995 nov./dec. 2019.                     ISSN 2595-6825 
 
 
5991  
edema in the feet and legs of the treated patients while the urea cream did not present this 
efficacy. It also proved to be more efficient than the urea cream in the elimination of pain in the 
feet of the patients. The healing process was not influenced by glycemia. 
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